
### [MONDO:0016138](http://purl.obolibrary.org/obo/MONDO_0016138)
**Label:** malignant lymphoma with peripheral neuropathy

**Subclasses:** [MONDO:0012491](http://purl.obolibrary.org/obo/MONDO_0012491) (WM2), [MONDO:0016101](http://purl.obolibrary.org/obo/MONDO_0016101) (neurolymphomatosis), [MONDO:0007926](http://purl.obolibrary.org/obo/MONDO_0007926) (Waldenstrom macroglobulinemia), 

**Mapped go classes:** [GO:0008063](http://purl.obolibrary.org/obo/GO_0008063) (Toll signaling pathway), [GO:0014069](http://purl.obolibrary.org/obo/GO_0014069) (postsynaptic density), [GO:0032494](http://purl.obolibrary.org/obo/GO_0032494) (response to peptidoglycan), [GO:0007254](http://purl.obolibrary.org/obo/GO_0007254) (JNK cascade), [GO:0007178](http://purl.obolibrary.org/obo/GO_0007178) (transmembrane receptor protein serine/threonine kinase signaling pathway), [GO:0051092](http://purl.obolibrary.org/obo/GO_0051092) (positive regulation of NF-kappaB transcription factor activity), [GO:1900017](http://purl.obolibrary.org/obo/GO_1900017) (positive regulation of cytokine production involved in inflammatory response), [GO:0043621](http://purl.obolibrary.org/obo/GO_0043621) (protein self-association), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0002755](http://purl.obolibrary.org/obo/GO_0002755) (MyD88-dependent toll-like receptor signaling pathway), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0002238](http://purl.obolibrary.org/obo/GO_0002238) (response to molecule of fungal origin), [GO:0050671](http://purl.obolibrary.org/obo/GO_0050671) (positive regulation of lymphocyte proliferation), [GO:0006915](http://purl.obolibrary.org/obo/GO_0006915) (apoptotic process), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0032760](http://purl.obolibrary.org/obo/GO_0032760) (positive regulation of tumor necrosis factor production), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0009682](http://purl.obolibrary.org/obo/GO_0009682) (induced systemic resistance), [GO:0032481](http://purl.obolibrary.org/obo/GO_0032481) (positive regulation of type I interferon production), [GO:0032680](http://purl.obolibrary.org/obo/GO_0032680) (regulation of tumor necrosis factor production), [GO:0005121](http://purl.obolibrary.org/obo/GO_0005121) (Toll binding), [GO:0043234](http://purl.obolibrary.org/obo/GO_0043234) (protein complex), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0010628](http://purl.obolibrary.org/obo/GO_0010628) (positive regulation of gene expression), [GO:0070555](http://purl.obolibrary.org/obo/GO_0070555) (response to interleukin-1), [GO:0010468](http://purl.obolibrary.org/obo/GO_0010468) (regulation of gene expression), [GO:0031663](http://purl.obolibrary.org/obo/GO_0031663) (lipopolysaccharide-mediated signaling pathway), [GO:0032675](http://purl.obolibrary.org/obo/GO_0032675) (regulation of interleukin-6 production), [GO:0050727](http://purl.obolibrary.org/obo/GO_0050727) (regulation of inflammatory response), [GO:0032755](http://purl.obolibrary.org/obo/GO_0032755) (positive regulation of interleukin-6 production), [GO:0090557](http://purl.obolibrary.org/obo/GO_0090557) (establishment of endothelial intestinal barrier), [GO:0043123](http://purl.obolibrary.org/obo/GO_0043123) (positive regulation of I-kappaB kinase/NF-kappaB signaling), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0048661](http://purl.obolibrary.org/obo/GO_0048661) (positive regulation of smooth muscle cell proliferation), [GO:2000338](http://purl.obolibrary.org/obo/GO_2000338) (regulation of chemokine (C-X-C motif) ligand 1 production), [GO:0032747](http://purl.obolibrary.org/obo/GO_0032747) (positive regulation of interleukin-23 production), [GO:0002218](http://purl.obolibrary.org/obo/GO_0002218) (activation of innate immune response), [GO:0045351](http://purl.obolibrary.org/obo/GO_0045351) (type I interferon biosynthetic process), [GO:0019221](http://purl.obolibrary.org/obo/GO_0019221) (cytokine-mediated signaling pathway), [GO:0032740](http://purl.obolibrary.org/obo/GO_0032740) (positive regulation of interleukin-17 production), [GO:0042802](http://purl.obolibrary.org/obo/GO_0042802) (identical protein binding), [GO:0070935](http://purl.obolibrary.org/obo/GO_0070935) (3'-UTR-mediated mRNA stabilization), [GO:0140052](http://purl.obolibrary.org/obo/GO_0140052) (cellular response to oxidised low-density lipoprotein particle stimulus), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:1902622](http://purl.obolibrary.org/obo/GO_1902622) (regulation of neutrophil migration), [GO:1901532](http://purl.obolibrary.org/obo/GO_1901532) (regulation of hematopoietic progenitor cell differentiation), [GO:1901534](http://purl.obolibrary.org/obo/GO_1901534) (positive regulation of hematopoietic progenitor cell differentiation), [GO:0007166](http://purl.obolibrary.org/obo/GO_0007166) (cell surface receptor signaling pathway), [GO:0005102](http://purl.obolibrary.org/obo/GO_0005102) (receptor binding), [GO:0005149](http://purl.obolibrary.org/obo/GO_0005149) (interleukin-1 receptor binding), [GO:0042127](http://purl.obolibrary.org/obo/GO_0042127) (regulation of cell proliferation), [GO:0060337](http://purl.obolibrary.org/obo/GO_0060337) (type I interferon signaling pathway), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0046330](http://purl.obolibrary.org/obo/GO_0046330) (positive regulation of JNK cascade), [GO:0016064](http://purl.obolibrary.org/obo/GO_0016064) (immunoglobulin mediated immune response), [GO:0030593](http://purl.obolibrary.org/obo/GO_0030593) (neutrophil chemotaxis), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:2000341](http://purl.obolibrary.org/obo/GO_2000341) (regulation of chemokine (C-X-C motif) ligand 2 production), [GO:0035325](http://purl.obolibrary.org/obo/GO_0035325) (Toll-like receptor binding), [GO:0070976](http://purl.obolibrary.org/obo/GO_0070976) (TIR domain binding), [GO:0045080](http://purl.obolibrary.org/obo/GO_0045080) (positive regulation of chemokine biosynthetic process), 

**Class expressions from DL-Learner:**

- Thing 52.79%
- [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium) 52.63%
- [GO:0009682](http://purl.obolibrary.org/obo/GO_0009682) (induced systemic resistance) 52.63%
- [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium) and [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response) 52.63%
- [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium) and [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response) 52.63%
- [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response) and [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium) 52.63%
- [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response) and [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium) 52.63%
- [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process) and [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium) 52.63%
- [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process) and [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium) 52.63%
- [GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) 48.10%
- [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium) 46.09%
- [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium) 46.09%
- [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium) and [GO:0098542](http://purl.obolibrary.org/obo/GO_0098542) (defense response to other organism) 46.09%
- [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response) and [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium) 46.09%
- [GO:0006950](http://purl.obolibrary.org/obo/GO_0006950) (response to stress) and [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium) 46.09%


